Gestational Trophoblastic Disease GOG 242
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II Study to Determine the Response to Second Curettage as Initial Management for Persistent Low Risk, Non-Metastatic Gestational Trophoblastic Neoplasia.